Regenerative Medicine Market Size to Reach Revenues of over USD 27 Billion by 2026 - Arizton

News provided by

May 25, 2021, 11:00 ET

CHICAGO, May 25, 2021 /PRNewswire/ -- In-depth analysis and data-driven insights on the impact of COVID-19 included in this global regenerative medicine market report.

The regenerative medicine market is expected to grow at a CAGR of over 30% during the period 2020−2026.

Key Highlights Offered in the Report:

The percentage share of gene therapy in the global market is more than 40% in 2020, which is expected to double by the year 2026.
As CAR-T therapy is widely popular these days for the treatment of chronic cancers, the key vendors in the market are increasing their focus on developing the products in CAR-T cell therapy. In February 2021 US FDA approved Breyanzi, a CAR-T cell therapy product to treat adults with relapsed or refractory large B-cell lymphoma.
The US is dominating the global regenerative medicine market with the highest absolute growth of more than 600% and growing at a double digit CAGR.
Mergers and acquisitions are increasing across the regenerative medicine market, the key players in the industry are acquiring the small developing companies, these companies are also more ready to merge with key players to enjoy the marketing benefits.
To sustain in the highly competitive market, the key players are increasing their focus on consistent product innovation in the field of regenerative medicine by investing huge amounts in the drug development processes.
The oncology therapeutic area dominates the regenerative medicine market, by capturing the market share of more than 30% in the year 2020 and is expected to capture the market share more than 50% by 2026, growing with the absolute growth of more than 700%. This is due to the increasing number of cancer cases around the globe where gene and CAR-T therapies are the popular treatments in curing the cancers.

Key Offerings:

Market Size & Forecast by Revenue | 2020−2026
Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities
Market Segmentation – A detailed analysis by application, products, end-users, and geography
Competitive Landscape – 7 key vendors and 32 other vendors

Get your sample today! https://www.arizton.com/market-reports/regenerative-medicine-market-size

Regenerative Medicine Market – Segmentation

Oncology constitutes the largest portion of the global regenerative medicine market share. The development of curative therapies by CAR-T and cell and gene therapies is widely popularized in the oncology therapeutic area. The increasing global prevalence rates and the increasing rates of different types of life-threatening cancers are the most important key factors that drive the oncology segment.
Consistent innovations in gene therapies due to the increased number of clinical trials and pipeline products are driving the growth prospects. Hence, the increased inflow of funding for the development of gene therapy is one of the driving factors for the sector growth Cell therapy is the major revenue contributor.
Hospitals are likely to remain a dominant revenue contributor to the global regenerative medicine market. Around 50% of therapeutic surgeries performed in the US annually, including cardiovascular and musculoskeletal, occur in hospitals. Cancer care centers are likely to witness an incremental growth of approx. USD 10 billion by 2026. As cancer is the second leading cause of death across the globe, which is responsible for approx. 10 million deaths annually, the scope of cancer centers is growing.

Regenerative Medicine Market by Application

Oncology
Genetic Disorders
Dermatology
Musculoskeletal
Others

Regenerative Medicine Market by Product

Gene Therapies
Cell Therapies
Tissue-Engineered Therapies

Regenerative Medicine Market by End-Users

Hospitals
Cancer Care Centers
Wound Care Centers
ASCs
Others

Regenerative Medicine Market – Dynamics

Regenerative medicine is expected to evolve and impact the overall healthcare industry in a positive way in the coming years. Among the global pharmaceutical companies, nearly 1000 companies are working on gene therapy, cell therapy, and tissue-engineering therapeutic products. Many companies worldwide have been developing a wide array of scaffolds that can be used in different tissue engineering applications, which cater to patients who require tissue and organ substitutes. The advances in scaffolds are attributable to several innovations in tissue scaffolds, bone scaffolds, and dental scaffolds. Tissue scaffolds basically act by integrating local cells in the desired shape of the scaffold after implantation. The scaffolds are of different types, such as cellusponge scaffolds in which cells are distributed in sponge pores and start growing. Collagen scaffolds have a unique porous network that allows diffusion of nutrients for cell growth, while hydrogel scaffolds have water content similar to natural tissue. Nanofiber scaffolds are transparent and ease cell imaging and quantification of cells.

Key Drivers and Trends fueling Market Growth:

Robust Product Pipeline of Regenerative Medicine Companies
Strategic Acquisitions by Regenerative Medicine Companies
Increase in Acute, Chronic, & Genetic Disorders
Increasing Demand for CAR T-cell and Gene Therapies

Regenerative Medicine Market – Geography

In 2020, North America accounted for a share of over 62% in the global regenerative medicine market. The region is expected to grow at a significant rate during the forecast period due to the highest number of RM companies in the world. The region has nearly 534 of the 987 RM companies worldwide. The growth is primarily attributable to the increasing incidence rates of different types of cancers such as non-Hodgkin lymphoma, Hodgkin lymphoma, melanoma of the skin, leukemia, and rare disorders, including Spinal muscular atrophy and multiple sclerosis. Cancer is the leading cause of death in North America. In 2018, nearly 1.9 million new cancer cases were reported in the North American region, along with 693,000 deaths. In the North American region, the US shows the highest prevalence rate for cancers such as non-Hodgkin lymphoma and other life-threatening rare diseases.

Get your sample today! https://www.arizton.com/market-reports/regenerative-medicine-market-size

Regenerative Medicine Market by Geography

North America

US
Canada

Europe

Germany
France
UK
Italy
Spain

APAC

Japan
China
Australia
South Korea
India

Latin America

Brazil
Mexico

Middle East & Africa

Turkey
Saudi Arabia
South Africa
UAE

Major Vendors

Novartis
Gilead Sciences
Amgen
Organogenesis
Bristol Myers Squibb
Vericle
Osiris Therapeutics

Other Prominent Vendors

Anges
Orchard Therapeutics
Orthofix
Integra Life Science
MiMedx
bluebird bio
Mesoblast
Avita Medical
Takeda Pharmaceuticals
Medipost
TissueTech
Misonix
J-TEC
Stempeutics
CO.DON
GC Pharma
Orthocell
Tego Science
Nipro
S-BIOMEDIC
APAC Biotech
Bio Solution
Chiesi Farmaceutici
Collplant
Corestem
Human Stem Cell Institute
JCR Pharmaceuticals
JW CreaGene
Nuvasive
Sibiono GeneTech
Shanghai Sunway Biotech
Terumo

Explore our healthcare & lifesciences profile to know more about the industry.

Read some of the top-selling reports:

About Arizton:

Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.

We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare, and life sciences, industrial machinery, chemicals and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.

Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

Mail: [email protected]
Call: +1-312-235-2040
+1 302 469 0707

SOURCE Arizton Advisory & Intelligence